Topic Review
Mechanical Heart Valve Patients with Intracranial Hemorrhage
The management of an intracranial hemorrhage in patients receiving anticoagulant therapy presents a significant challenge for medical professionals. Anticoagulant treatment is intended to prevent blood clotting, but it can worsen active brain bleeds. Despite this risk, avoiding the prothrombotic state caused by mechanical heart valves remains crucial. 
  • 699
  • 17 May 2023
Topic Review
Therapeutic Applications of Calendula officinalis
Calendula officinalis Linn. (CO) is a popular medicinal plant from the plant kingdom’s Asteraceae family that has been used for millennia. This plant contains flavonoids, triterpenoids, glycosides, saponins, carotenoids, volatile oil, amino acids, steroids, sterols, and quinines. These chemical constituents confer multifaceted biological effects such as anti-inflammatory, anti-cancer, antihelminthic, antidiabetes, wound healing, hepatoprotective, and antioxidant activities. Additionally, it is employed in cases of certain burns and gastrointestinal, gynecological, ocular, and skin conditions. 
  • 698
  • 05 May 2023
Topic Review
Inflammation and Specialized Pro-Resolving Mediators in Atherosclerosis
Atherosclerosis, a disease of the arteries set off initially by fat deposition, is a major cause of life-threatening cardiovascular events. It was long thought to be a passive process caused by the accumulation of cholesterol within the lumen of arteries resulting in ischemia and an eventual complete blockage. Arteries are composed of endothelial cells (EC), elastin, collagen, and smooth muscle cells. ECs line the lumen of vessels and are subject to physical demands, such as shear stress, imposed by the flow of blood. Such stressors fluctuate and vary through the length of the artery, owing to the rheological properties of the blood and vulnerable areas of the arteries, such as branching points. Atherosclerosis is now known to be an active chronic inflammatory disease. Recently inflammation resolution has garnered great interest, as studies showed that it is active concerted effort by a class of specialized molecules termed SPMs, which led to look at treating that inflammation by enhancing its resolution.
  • 696
  • 18 Nov 2022
Topic Review Peer Reviewed
COVID-19 and Coronary Heart Disease
Coronary heart disease (CHD) is the leading cause of mortality worldwide. One of the main contributions of mortality and morbidity in CHD patients is acute myocardial infarction (AMI), which is the result of abrupt occlusion of an epicardial coronary artery due to a sudden rupture of atherosclerotic plaque, causing myocardial ischemia. In the initial stage of myocardial ischemia, lack of oxygen and nutrient supply results in biochemical and metabolic changes within the myocardium. Depletion of oxygen switches the aerobic cellular metabolism to anaerobic metabolism and impairs the oxidative phosphorylation pathway eventually leading to cardiomyocyte death. Several studies suggest an interlink between COVID-19 and ischemic heart disease. An increased ACE2 receptor expression in the myocardium may partly contribute to the myocardial injuries that are observed in patients affected by SARS-CoV-2. Furthermore, pre-existing cardiovascular disease, in conjunction with an aggravated inflammatory response which causes an up-regulation in pro-inflammatory cytokines. Moreover, patients with atherosclerosis are observed to be more prone to ischemic attacks when affected by COVID-19, due to hypercoagulation in the blood as well as elevated pro-inflammatory markers.
  • 694
  • 13 Apr 2022
Topic Review
Computed angiotomography for Preoperative TAVR Planning
Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for patients with severe symptomatic aortic stenosis (AS) whose procedural efficacy and safety have been continuously improving. Appropriate preprocedural planning, including aortic valve annulus measurements, transcatheter heart valve choice, and possible procedural complication anticipation is mandatory for a successful procedure. The gold standard for preoperative planning is still to perform a multi-detector computed angiotomography (MDCT), which provides all the information required. The planning can be performed manually, using semi-automated and automated software.
  • 693
  • 23 May 2022
Topic Review
Studying Epigenetics of Cardiovascular Diseases on Chip Guide
Epigenetics is defined as the study of inheritable changes in the gene expressions and phenotypes that occurs without altering the normal DNA sequence. These changes are mainly due to an alteration in chromatin or its packaging, which changes the DNA accessibility. DNA methylation, histone modification, and noncoding or microRNAs can best explain the mechanism of epigenetics. There are various DNA methylated enzymes, histone-modifying enzymes, and microRNAs involved in the cause of various CVDs (cardiovascular diseases) such as cardiac hypertrophy, heart failure, and hypertension. Moreover, various CVD risk factors such as diabetes mellitus, hypoxia, aging, dyslipidemia, and their epigenetics are also discussed together with CVDs such as CHD (coronary heart disease) and PAH (pulmonary arterial hypertension). Furthermore, different techniques involved in epigenetic chromatin mapping are explained.
  • 693
  • 13 Jul 2022
Topic Review
Nrf2 and HO-1 in Atherosclerosis
Oxidative stress mediated by reactive oxygen species (ROS) plays a key role in the atherosclerotic process. ROS not only oxidize LDL, they also promote several pro-atherogenic effects, including inflammation, apoptosis, and alteration of vascular tone. The imbalance between pro- and antioxidant agents drives to the formation and progression of atherosclerotic plaque lesions. In this sense, the transcription factor Nuclear factor–erythroid 2-related factor 2 (Nrf2) is known to activate the expression of more than 250 antioxidant enzymes—such as heme oxygenase-1 (HO-1), glutathione peroxidase, or glutamate-cysteine ligase —making it a master regulator of oxidative stress. Nrf2 has been associated with different cardiovascular-related pathologies—such as obesity, diabetes mellitus, atherosclerosis, hypertension, or heart failure. Currently, Nrf2 signaling pathway is considered an important defense mechanism against cardiovascular diseases (CVDs).
  • 690
  • 11 Oct 2021
Topic Review
Treatment of Transthyretin Amyloid Cardiomyopathy
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressively debilitating, rare disease associated with high mortality. ATTR-CM occurs when TTR amyloid protein builds up in the myocardium along with different organs, most commonly the peripheral and the autonomic nervous systems. Managing the cardiac complications with standard heart failure medications is difficult due to the challenge to maintain a balance between the high filling pressure associated with restricted ventricular volume and the low cardiac output. To date, tafamidis is the only agent approved for ATTR-CM treatment.
  • 690
  • 06 May 2022
Topic Review
Stereotactic Arrhythmia Radioablation
Ventricular tachycardia is a type of arrhythmia (heart rhythm disorder) characterized by fast heart rate (exceeding 100 beats per minute), originating from abnormal electrical impulse localized in heart ventricles. The electrophysiology-guided noninvasive cardiac radioablation, also known as STAR (stereotactic arrhythmia radioablation), is an emerging treatment method of non-invasive treatment for ventricular tachycardia persistent after conventional methods of ablation.
  • 687
  • 10 May 2021
Topic Review
K2P Potassium Channels to Cardiac
Two-pore domain potassium (K2P) channels are the latest potassium channels family to be described. Since the discovery of the first member of the TWIK subfamily, the 15 known K2P channels cloned to date have been grouped into six different subfamilies: TIWK; TREK; TASK; THIK; TRESK; and TALK. In mammals, K2P channels are expressed in both nervous and non-nervous tissue, and their distribution varies widely from the almost ubiquitous expression of TWIK to the weak pancreatic expression of TALK.
  • 685
  • 18 Aug 2021
Topic Review
Antioxidants in Arrhythmia Treatment
Antioxidants are substances that can prevent damage to cells caused by free radicals. Production of reactive oxygen species and the presence of oxidative stress play an important role in cardiac arrhythmias.
  • 685
  • 15 Jun 2022
Topic Review
Cardiorenal Protection with Sodium-Glucose Co-Transporter 2 Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) is a family of glucose transporter proteins localized in the proximal tubule of the nephron, responsible for the majority of filtered glucose and sodium reabsorption, and SGLT2 inhibitors (SGLT2-Is) are novel drugs for the treatment of T2DM and heart failure.
  • 685
  • 18 Oct 2022
Topic Review
ICIs-Related Cardiotoxicity in Different Types of Cancer
Immune checkpoint inhibitors (ICIs), antibodies that target the checkpoints in immune cells, work to activate inhibited T-cells and other cells of the innate and adaptive arms, resulting in the robust activation of the immune system and productive antitumor immune responses. However, ICIs-related cardiotoxicity has been recognized as a rare but fatal consequence. Although there has been extensive research based on different types of ICIs, these studies have not indicated whether cardiotoxicity is specific to a type of cancer.
  • 683
  • 13 Jul 2022
Topic Review
Apps for Coronary Heart Disease
Mobile health applications (MHA) are discussed to contribute in overcoming this gap in treatment by fostering CHD management. First, MHA may support daily monitoring of activities and symptoms. Second, adherence to treatment and lifestyle changes can be increased by self-tracking, feedback, and reminder functions of MHA.
  • 682
  • 28 Oct 2021
Topic Review
Modeling Human Cardiac Arrhythmias: Insights from Zebrafish
Cardiac arrhythmia, or irregular heart rhythm, is associated with morbidity and mortality and is described as one of the most important future public health challenges. In the last few decades, the zebrafish has emerged as an attractive model to reproduce in vivo human cardiac pathologies, including arrhythmias. As genetic tools in zebrafish continue to bloom, this model will be crucial for functional genomics studies and to develop personalized anti-arrhythmic therapies.
  • 681
  • 21 Jan 2022
Topic Review
Definition of Hypertension and Establishment of Treatment Targets
Hypertension is the most frequent chronic and non-communicable disease all over the world, with about 1.5 billion affected individuals worldwide. Its impact is currently growing, particularly in low-income countries. Even in high-income countries, hypertension remains largely underdiagnosed and undertreated, with consequent low rates of blood pressure (BP) control.
  • 681
  • 21 Mar 2022
Topic Review
Computational Simulations of Heart Valves
Computational methods are a cost-effective tool that can be used to evaluate the flow parameters of heart valves. Valve repair and replacement have long-term stability and biocompatibility issues, highlighting the need for a more robust method for resolving valvular disease. For example, while fluid–structure interaction analyses are still scarcely utilized to study aortic valves, computational fluid dynamics is used to assess the effect of different aortic valve morphologies on velocity profiles, flow patterns, helicity, wall shear stress, and oscillatory shear index in the thoracic aorta. It has been analyzed that computational flow dynamic analyses can be integrated with other methods to create a superior, more compatible method of understanding risk and compatibility.
  • 681
  • 10 May 2022
Topic Review
Personalized Cell Therapy for PAD
Stem/progenitor cell transplantation is a potential novel therapeutic strategy to induce angiogenesis in ischemic tissue, which can prevent major amputation in patients with advanced peripheral artery disease (PAD). Some studies have indicated that the response to stem cell therapy varies among patients, even in those harboring limited risk factors.
  • 680
  • 10 Dec 2021
Topic Review
The Angiogenic Balance
Angiogenesis is the process of developing new blood vessels from pre-existing ones.
  • 680
  • 28 Jul 2022
Topic Review
KCNJ5 Mutation in Aldosterone Producing Adenoma
The discovery of the KCNJ5 somatic mutation in aldosteroene producing adenoma (APA) in 2011 and the development of specific CYP11B2 antibodies in 2012 have greatly advanced our understanding of the pathophysiology of primary aldosteronism. PA leads to abnormalities in the renin-angiotensin-aldosterone system and is known to increase the incidence of atrial fibrillation, heart failure, and stroke by 3.52, 2.05, and 2.58 times compared to hypertension due to essential hypertension.
  • 676
  • 26 Aug 2022
  • Page
  • of
  • 45
ScholarVision Creations